uBriGene
About:
uBriGene is driven by the advancement of gene and cell therapy technologies through research and development.
Website: http://www.ubrigene.com
Top Investors: Cowin Capital, Addor Capital, IDG Capital, Huagai Capital, CLSA
Description:
Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.
Total Funding Amount:
$68M
Headquarters Location:
Miyun, Beijing, China
Founded Date:
2015-01-01
Founders:
Qichen Li
Number of Employees:
501-1000
Last Funding Date:
2023-04-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai